Manuscripts

Search by keyword, year, or author name.

Showing 1551 manuscripts.

Dextran sulfate is poorly absorbed after oral administration

Kevin Lorentsen, Craig Hendrix, Jerry Collins, David Kornhauser, Brent Gray Petty, Paymong W. Klecker, Charles Flexner, Robert H. Eckel, Paul S. Lietman. Dextran sulfate is poorly absorbed after oral administration. Annals of Internal Medicine. 1989. 111: 561-6.

Year

1989

Journal

Annals of Internal Medicine

Clinical role of granulocyte-macrophage colony-stimulating factor

Ronald T. Mitsuyasu, David W. Golde. Clinical role of granulocyte-macrophage colony-stimulating factor. Hematology/Oncology Clinics of North America. 1989. 3: 411-25.

Year

1989

Journal

Hematology/Oncology Clinics of North America

Human immunodeficiency virus infection. Clinical diagnosis

William G. Powderly. Human immunodeficiency virus infection. Clinical diagnosis. Missouri Medicine. 1989. 86: 625-7.

Year

1989

Journal

Missouri Medicine

Generation and administration of aerosols for medical and physiological research studies

Gerald C. Smaldone. Generation and administration of aerosols for medical and physiological research studies. Journal of Aerosol Medicine. 1989. 2: 81-7.

Year

1989

Journal

Journal of Aerosol Medicine

Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidine

Margo Smith, E. L. Brian, Joseph S. Pagano. Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidine. Antimicrobial Agents and Chemotherapy. 1989. 33: 1482-6.

Year

1989

Journal

Antimicrobial Agents and Chemotherapy

Oxidative burst capability of human monocyte subsets defined by high and low HLA-DR expression

Greg Spear, Robert A. June, Alan Landay. Oxidative burst capability of human monocyte subsets defined by high and low HLA-DR expression. Immunological Investigations. 1989. 18: 993-1005.

Year

1989

Journal

Immunological Investigations

Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone

Stephen A. Spector, D. Ripley, Karen Hsia. Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone. Antimicrobial Agents and Chemotherapy. 1989. 33: 920-3.

Year

1989

Journal

Antimicrobial Agents and Chemotherapy

A culture method allowing production of relatively pure Pneumocystis carinii trophozoites

Michelle M. Durkin, Marilyn S. Bartlett, Sherry F. Queener, Margaret M. Shaw, James W. Smith. A culture method allowing production of relatively pure Pneumocystis carinii trophozoites. Journal of Protozoology. 1989. 36: 31S-32S.

Year

1989

Journal

Journal of Protozoology

In vivo and in vitro ultrastructural alterations induced by human immunodeficiency virus in human lymphoid cells

B. Yoffe, Barbara L. Petrie, C. A. Noonan, F. Blaine Hollinger. In vivo and in vitro ultrastructural alterations induced by human immunodeficiency virus in human lymphoid cells. Laboratory Investigation. 1989. 61: 303-9.

Year

1989

Journal

Laboratory Investigation

Intravenous recombinant tumor necrosis factor in the treatment of AIDS-related Kaposi's sarcoma

D. Aboulafia, Steven A. Miles, Samuel R. Saks, Ronald T. Mitsuyasu. Intravenous recombinant tumor necrosis factor in the treatment of AIDS-related Kaposi's sarcoma. Journal of Acquired Immune Deficiency Syndromes. 1989. 2: 54-8.

Year

1989

Journal

Journal of Acquired Immune Deficiency Syndromes